If all low- and middle-income countries had achieved the same level of antiretroviral treatment (ART) coverage as Botswana in 2012, 65% of new HIV infections and 70% of HIV-related deaths could have been prevented -- according to an analysis presente...
Transgender Services and Clinics: Interviews at AIDS 2014 With JoAnne Keatley and Beatriz Grinsztejn
JoAnne Keatley is a leading transgender activist and Dr. Beatriz Grinsztejn developed the first transgender HIV clinic in Rio de Janiero.
Where available -- and information is scarce even from resource-rich countries -- data increasingly report very high rates of HIV in transgender people, especially those who have sex with men.
What did long-term survivors -- people who have lived with HIV for more than 20 years -- have to say about their health and other issues at AIDS 2014?
The conference, which opened with loss and determination to persevere -- begins to close, as delegates share the last round of studies, strategies and stories of struggle before returning to the comfort or challenges of home.
The leading medical journal asserts that decriminalization of sex work could have the largest effect on the course of the HIV epidemic, stopping 33% to 46% of incident infections in the next 10 years.
A Human Rights Watch researcher at AIDS 2014 asserts that international law on human rights and public health obligates the U.S. to provide education, care and rights for U.S. Southerners.
The session took on common myths about trans MSM -- often left out of conversations, care and research -- and called for respectful and safe access to testing, information, research and care.
Bloomberg Businessweek: Wives Hide HIV as Stigma Undermines Progress on AIDS
"... Protecting young mothers will be critical if the world is to meet a U.N. target of eliminating new HIV infections among children by 2015. At an international AIDS meet...
The PARTNERS study showed a lot of promise for treatment as prevention, and could also have a lot of positive repercussions regarding pre-exposure prophylaxis (PrEP). A few leading researchers weigh in.